Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 6/20 | 0.51 |
| ▸ | NPY1R | P25929 | 1/20 | 0.47 |
| ▸ | NPY2R | P49146 | 1/20 | 0.47 |
| ▸ | NPY4R | P50391 | 1/20 | 0.47 |
| ▸ | ACE | P12821 | 2/20 | 0.47 |
| ▸ | IL1RN | P18510 | 1/20 | 0.45 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.45 |
| ▸ | KISS1R | Q969F8 | 4/20 | 0.45 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.44 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.44 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30449279 | 0.92 | BACE1 (0.51) | BACE1 | |
| SCHEMBL31274737 | 0.91 | MME (0.50) | ACEOPRD1 | |
| SCHEMBL31307241 | 0.89 | BACE1 (0.57) | BACE1 | |
| SCHEMBL29531471 | 0.88 | ACE (0.47) | NPY1RNPY2RNPY4RACEOPRD1 | |
| SCHEMBL5699005 | 0.88 | BACE1 (0.49) | BACE1NPY1RNPY2RNPY4RACE | |
| SCHEMBL5699001 | 0.88 | BACE1 (0.49) | BACE1NPY1RNPY2RNPY4RACE | |
| SCHEMBL29705780 | 0.88 | OPRD1 (0.54) | NPY1RNPY2RNPY4RACEIL1RN | |
| SCHEMBL30034864 | 0.88 | NPY1R (0.53) | NPY1RNPY2RNPY4RACEIL1RN | |
| SCHEMBL31114994 | 0.86 | NPY4R (0.44) | NPY1RNPY2RNPY4RIL1RNERAP2 | |
| SCHEMBL30350938 | 0.86 | KISS1R (0.57) | BACE1NPY1RNPY2RNPY4RACE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025002590-A1 | TISSUE MHC CLASS I IMMUNOPEPTIDE PATTERN DEDICATED FOR GENERATION OF ANTI-CANCER VACCINES AGAINST NON-SMALL CELL LUNG CANCER (NSCLC), IDENTIFICATION AND ISOLATION OF NSCLC SPECIFIC T CELLS IN HUMANS | UNIWERSYTET GDÁNSKI (PL) | 2025-01-02 | — | — | WO | claimed |